We believe
in the uniqueness of human beings and therefore in the personalised treatment of diabetes.
We believe
in the uniqueness of human beings and therefore in the personalised treatment of diabetes.
We believe
in the uniqueness of human beings and therefore in the personalised treatment of diabetes.
Because there is no break from diabetes.
Diabetes management is complex and personal, and achieving therapy goals is an on-going challenge. That’s why a comprehensive approach to care is needed – one that helps maximise time and resources, generates meaningful clinical and patient-relevant outcome data, and deepens your connections with patients, peers and administrators.
integrated Personalised Diabetes Management (iPDM)
We offer a holistic, patient-centric approach to diabetes management to bring true relief to People with Diabetes worldwide.
We leverage connected devices, services and digital products to personalise solutions that limit the progression of the disease, strengthen HCP, Patient and Payer collaboration, and improve outcomes to contribute to healthcare system sustainability.
United we advance the way diabetes is treated.
Proven results –
through a more personalised approach.
Multiple studies have helped us pioneer our way towards iPDM to improve therapy outcomes.
efficient processes
- More frequent and timely therapy adjustments1-5
- Faster and more accurate decision-making6
- Greater clinician efficiency1,3,6
- Greater clinician satisfaction1,3,5
clinical outcomes
- Reduced therapeutic inertia1-4
- Improved HbA1C with no increase in hypoglycaemia1-3
- Reduced glycaemic variability2,3
- Better postprandial control2,3
patient collaboration
- Higher treatment satisfaction1,3,4
- Improved therapy adherence1,3
- Enhanced patient understanding3,6
- Improved patient self-efficacy7
A patient-centred open ecosystem.
Our open ecosystem enables the four key areas of iPDM – connectivity, personalised care, collaboration and healthcare sustainability. Helping us to shape and advance the way diabetes care is provided in the future.
1. Kulzer B, Daenschel W, Daenschel I, et al. Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program. Diabetes Res Clin Pract. 2018;144:200-12. 2. Polonsky WH, Fisher L, Schikman CH, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011;34(2):262-7. 3. Weissmann J, Mueller A, Messinger D, et al. Improving the Quality of Outpatient Diabetes Care Using an Information Management System: Results From the Observational VISION Study. Journal of diabetes science and technology. 2015;10(1):76-84. 4. Mora P, Buskirk A, Lyden M, et al. Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management Study. Diabetes technology & therapeutics. 2017;19(12):715-22. 5. Brotons C, et al. Benefits of a Blood Glucose Data Reader Device in the Management of Type 2 Diabetes Mellitus: Primary Care Nurses Perspective. Presented at Advanced Technologies & Treatments for Diabetes (ATTD) 5th International Conference; February 8-11; Barcelona, Spain. 2012. 6. Hinnen DA, Buskirk A, Lyden M, et al. Use of diabetes data management software reports by health care providers, patients with diabetes, and caregivers improves accuracy and efficiency of data analysis and interpretation compared with traditional logbook data: first results of the Accu-Chek Connect Reports Utility and Efficiency Study (ACCRUES). J Diabetes Sci Technol. 2015;9(2):293-301. 7. Kulzer B, Heinemann L, Hochstadt S, et al. Wie digital ist die Diabetologie in Deutschland? : Ergebnisse des Digitalisierungs- und Technologiereports Diabetes 2019. Diabetes, Stoffwechsel und Herz. 2019;28(4):189-96.